Read + Share
Amedeo Smart
Independent Medical Education
Loglio A, Ferenci P, Uceda Renteria SC, Tham CYL, et al. Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis. J Hepatol 2021 Oct 23. pii: S0168-8278(21)02119.PMID: 34699951
Email
LinkedIn
Facebook
Twitter
Privacy Policy